U.S. Retail REITs Stock News

Thinking about what to do with Baker Hughes stock right now? You are not alone. After a year when shares surged nearly 40%, and with the stock climbing more than 8% just in the last month, it is natural to wonder whether this momentum has more room to run or if it is time for a pause. While daily headlines and global energy news swirl around oil and gas demand, Baker Hughes has quietly delivered reliable growth, reflecting both sector strength and investor appetite for industrial...

If you have been following Daktronics (DAKT) lately, the recent flurry of headlines might make you stop and reconsider your strategy. The company just posted earnings that flipped last year’s net loss into a healthy profit for the first quarter, signaling a dramatic turnaround in profitability. In addition, Daktronics wrapped up a meaningful buyback tranche, reinforcing confidence in the company’s balance sheet and future outlook. Both announcements hit the market at the same time, giving...

Thinking about what to do with Absci (ABSI) stock after its recent announcement? You are not alone. Absci just revealed a technology partnership with Oracle Cloud Infrastructure and AMD that could be a tipping point for its AI-powered drug discovery ambitions. By teaming up, these companies aim to streamline Absci’s biologics design cycles, make simulations more efficient, and reduce operational costs. That is the kind of event that tends to spark fresh questions from both growth seekers and...

As you weigh your next move with C.H. Robinson Worldwide (CHRW), there is a new variable in play. The company just rolled out a cross-border freight service designed to address some of the toughest pain points for shippers moving goods between Mexico, the United States, and Canada. By consolidating less-than-truckload shipments in Mexico and using AI-driven route optimization, C.H. Robinson aims to cut costs, boost visibility, and help clients navigate tariff hurdles more effectively. For...

In the past week, Kohl's was identified as an emerging 'meme stock' amid heightened social media activity and significant short interest, while also reporting a 4.2% year-over-year decrease in comparable sales for its second quarter of 2025. Although the company raised its full-year profit outlook, it forecasted a 5% to 6% decline in annual sales, highlighting persistent challenges despite recent investor attention. We'll examine how social media-driven trading and ongoing sales declines are...

Ryman Hospitality Properties (RHP) has been moving quietly on the market, catching the attention of investors who are always on the hunt for hints about what might come next. While there hasn't been a single headline-grabbing event or announcement to explain this recent movement, the subtle shifts in the price may have some wondering if this signals an opportunity hiding in plain sight or something investors are already pricing in. Looking at the bigger picture, Ryman Hospitality Properties...

Teleflex Incorporated recently announced that the first patient has been enrolled in the DUBSTENT DIABETES trial, a randomized clinical study comparing dual-device and single-device strategies for percutaneous coronary intervention in diabetic patients using its Pantera Lux Drug-Coated Balloon Catheter and Orsiro Mission Drug-Eluting Stent. This trial addresses a significant challenge in cardiovascular care, as diabetic patients continue to face higher rates of stent failure despite medical...

Earlier this month, Tri Pointe Homes announced the acquisition of two land parcels in Leander, Texas, where it plans to build 150 new homes across the Ridgeview Reserve and Noven neighborhoods, targeting premium homebuyers with completion expected around summer 2026. This expansion reflects Tri Pointe Homes’ focus on high-growth markets and highlights its ongoing efforts to respond to local housing demand through geographic and product development. We'll now explore how this major land...

If you are on the fence about what to do with HP stock right now, you're definitely not alone. Plenty of investors are taking a closer look after seeing the stock close at $27.97, with movements that have made for an interesting ride. In just the past week, HP slid by 4.7%. Zoom out a little and the picture changes, with a 4.6% gain over the last month. Year to date, it is still down 13.9%, and even the last twelve months show a 13.8% drop. Step back a few years, and you'll see an entirely...

If you’ve been tracking Xeris Biopharma Holdings (XERS), you probably noticed the recent jump in excitement around the stock. A fresh wave of analyst upgrades and positive earnings estimate revisions have set the tone, reinforcing what momentum watchers have suspected: investors are taking another look at Xeris as near-term prospects brighten up. These triggers have moved sentiment quickly, and for anyone considering adding XERS to their portfolio, it feels like a moment when signals are...

In September 2025, Allegiant Travel Company raised its third-quarter earnings guidance and reported strong preliminary passenger traffic results for August, reflecting growth in both scheduled service and total system passengers compared to the prior year. This surge in operational performance coincided with the announcement of new nonstop leisure routes for 2026, underscoring the airline's emphasis on expanding value-driven travel options and improving cost structure. We'll examine how...

On September 9, 2025, Corebridge Financial announced that Marc Costantini will become its new President and CEO effective December 1, 2025, replacing Kevin Hogan, who will transition to a special advisor role for six months. This leadership change brings in an executive with deep experience in financial services strategy and product innovation, signaling a new direction for the company's ongoing development. We'll explore how Marc Costantini's appointment as CEO could influence Corebridge...

If you have been watching Synchrony Financial (SYF) lately, you might have noticed a wave of renewed buzz around the stock. The latest round of Wall Street analyst updates has doubled down on Buy ratings, citing Synchrony's strong position across retail cards, payment solutions, and CareCredit. These calls have come alongside fresh recognition for the stock’s compelling valuation metrics, further elevating the debate for investors wondering how much upside remains in today's prices. The...

If you are wondering what to make of Delek Logistics Partners (DKL) right now, you are not alone. After a stretch of coverage highlighting its accelerating earnings growth and a sudden move up in analyst earnings estimates, the stock has been getting fresh attention. Investors have taken note, as the company’s upbeat outlook and improved fundamentals seem to be translating into rising confidence in its future prospects. This uptick in optimism has coincided with DKL outperforming its...

If you have been tracking Americold Realty Trust (COLD), their latest move might have caught your eye. The company just declared a $0.23 per share dividend for Q3 2025, holding steady with last quarter and representing a 5% increase compared to the same period a year ago. For many investors, a dividend hike like this is a powerful signal and is often interpreted as a sign that management feels confident about the company’s underlying earnings strength and visibility. When a board votes to pay...

Coupang recently reported strong revenue growth and margin expansion, propelled by ongoing investments in automation, artificial intelligence, and cloud services, even as it faces a challenging Asian economic climate. Recent developments include the dismissal of a shareholder lawsuit from Coupang’s 2021 IPO and divergent analyst views, highlighting both growing business momentum and near-term caution about earnings potential. With Coupang's technology investments driving efficiency and new...

Earlier this month, Paychex, Inc. announced the launch of an integrated accounts payable solution powered by BILL Holdings, aiming to provide SMBs using Paychex Flex with automation of payroll, HR, and bill payments through one seamless platform. This development coincides with heightened activist investor attention, as both Elliott Management and Starboard Value have recently taken significant stakes in BILL Holdings and are pushing for Board changes, signaling possible shifts in governance...

If you have been watching Strategic Education (STRA), the latest round of analyst updates probably got your attention. Following fresh earnings data showing mixed student enrollment trends but standout growth in the company’s Sophia Learning segment, two major analysts have reiterated their buy ratings and called out the company’s fundamentals. This flurry of renewed interest comes on the heels of adjusted earnings per share beating expectations, hinting that the company may be turning a...

Earlier this month, Lazard Inc. disclosed that Evan Russo, CEO of Asset Management, sold 75,000 shares and also announced the appointments of Bill Young and Jean Greene as new managing directors, as well as Dmitry Shevelenko joining the board on September 2, 2025. The series of insider sales, including Russo's transactions totaling 200,000 shares in the past year with no insider buys, has drawn investor attention regarding management’s confidence in the company’s outlook. We’ll now review...

Earlier this week, reAlpha Tech Corp. announced an upgrade to its internal AI Loan Officer Assistant, enhancing mortgage automation by streamlining document classification, extraction, and validation for over 75 types of borrower documents using advanced OCR and generative AI. This latest advancement is designed to free loan officers from repetitive tasks, enabling more focus on advising borrowers and strengthening compliance oversight. We'll explore how this expanded AI integration and...

Corcept Therapeutics recently announced that the FDA has accepted its New Drug Application for relacorilant as a potential treatment for patients with platinum-resistant ovarian cancer, assigning a PDUFA date of July 11, 2026. This regulatory milestone is based on positive Phase 2 and 3 trial data showing improved survival rates without added safety risks, and highlights relacorilant’s potential to address an unmet need in a difficult-to-treat cancer population. We'll explore how the FDA's...

Earlier this month, Flowers Foods increased its quarterly dividend by 3.1% to US$0.2475 per share, and long-serving board director Melvin T. Stith announced he will retire at the end of 2025. These leadership and capital return announcements come alongside executive share sales and follow commentary highlighting ongoing shifts within the company's bread and premium bakery segments. We'll examine how the dividend increase and board transition could influence Flowers Foods' investment...

Loews (L) Shares Hit All-Time High After Strong Earnings and Governance Moves If you own Loews (L) or are thinking about getting in, you have probably noticed the recent buzz. The stock just hit an all-time high, and it is not hard to see why. Loews reported a 6% increase in second-quarter net income, a sign that its operations are firing on all cylinders. On top of that, the company announced a dividend, rewarding shareholders and highlighting management’s confidence. In addition, Loews...

If you have been watching Shopify, you are not alone. The company’s explosive long-term gains often spark the classic debate: hold, sell, or jump in now? Whether you are a long-term bull or a cautious skeptic, Shopify’s recent price action gives everyone something to talk about. In the last week, shares slipped by 1.9%, but over the past month, they have managed to eke out a 1.4% gain. Looking longer-term, the year-to-date move sits at an impressive 33.3%, and the stock has soared a whopping...